+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice



Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice



European Journal of Pharmacology 321(3): 265-271



Modulation of the reinforcing effects of cocaine and morphine by the kappa-opioid receptor agonist U50,488H (trans-3,4-dichloro-N-methyl-N-(2-1-pyrrolidinyl)-cyclohexyl-benzeace tamide) was studied by using the method of intravenous (i.v.) self-administration in drug-naive Wistar rats and DBA/2 mice. Self-administration of cocaine (by rats) and morphine (by mice) was readily initiated and showed an inverted U-shaped unit dose-response curve. Treatment with the kappa-opioid receptor agonist U50,488H dose dependently decreased the intake of both cocaine and morphine when offered in doses that readily initiated and sustained self-administration behavior. Interestingly, treatment with U50,488H induced self-administration behavior with lower sub-threshold doses of cocaine and morphine. With regard to the inverted U-shaped relation between the dose of the drug and the number of self-infusions, it seems that activation of the kappa-opioid receptor with U50,488H produced an almost parallel shift to the left, indicating an increased sensitivity of the animals for the reinforcing effects of cocaine and morphine. These data demonstrate an involvement of kappa-opioid systems in the neurobiological mechanisms underlying drug addiction in general, and sensitivity for drug reward in particular. Furthermore, the dual effect of kappa-opioid receptor agonists on drug self-administration may prompt further research into the mechanisms underlying the role of endogenous opioids in drug self-administration.

(PDF emailed within 1 workday: $29.90)

Accession: 008932859

Download citation: RISBibTeXText

PMID: 9085036


Related references

Kappa-opioid receptor blockade with nor-binaltorphimine modulates cocaine self-administration in drug-naive rats. European Journal of Pharmacology 358(3): 197-202, 1998

Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal. Embo Journal 17(4): 886-897, 1998

Disability of development of tolerance to morphine and U-50,488H, a selective kappa-opioid receptor agonist, in neuropathic pain model mice. Journal of Pharmacological Sciences 94(3): 305-312, 2004

Effect of chronic administration of naltrexone on brain mu- and kappa-opioid receptors and responses to U-50,488H, a kappa-opioid receptor agonist in the mouse. FASEB Journal 9(3): A102, 1995

Effects of a selective kappa-opioid agonist, U-50,488H, on morphine dependence in rats. European Journal of Pharmacology 170(1-2): 47-51, 1989

A selective kappa-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats. European Journal of Pharmacology 156(1): 173-176, 1988

The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats. Journal of Pharmacology and Experimental Therapeutics 264(2): 631-637, 1993

U-50,488H, a selective kappa opioid receptor agonist, ameliorates memory impairments induced by muscarinic autoreceptor agonist, carbachol in mice. Neuroscience Letters 236(1): 45-48, 1997

Effect of repeated administration of U-50,488H, a kappa opioid receptor agonist, on central 5-HT1 and 5-HT2 receptors in the rat. Pharmacology 39(3): 145-153, 1989

Effects of U-50,488H on isolated atria from rats chronically treated with the kappa-opioid agonist, U-50,488H. Journal of Autonomic Pharmacology 18(6): 371-375, 1999

Effect of chronic administration of U-50,488H, a kappa-opioid receptor agonist, on central dopamine D2 receptors of the rat. European Journal of Pharmacology 235(1): 23-30, 1993

Effects of the selective kappa-opioid agonist U50488 upon the electrical activity of supraoptic neurones in morphine-tolerant and morphine-naive rats. Experimental Brain Research. 94(2): 237-246, 1993

Effects of U-50,488H, a kappa-opioid receptor agonist, on the learned helplessness model of depression in mice. Journal of Neural Transmission 109(9): 1221-1225, 2002

Effect of kappa-opioid receptor agonists on morphine analgesia in morphine-naive and morphine-tolerant rats. European Journal of Pharmacology 156(2): 239-246, 1988

Contralateral, ipsilateral and bilateral treatments with the kappa-opioid receptor agonist U-50,488H in mononeuropathic rats. European Journal of Pharmacology 494(2-3): 139-146, 2004